Related Experiment Video

Updated: Aug 9, 2025

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

503

Serologic Studies in Membranous Nephropathy: Novel Strategies and Strengthened Associations

Tiffany N Caza1, Christopher P Larsen

  • 1Arkana Laboratories, Little Rock, Arkansas.

Kidney360
|February 23, 2023
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Author Spotlight: Expanding the Scope of Multiplex Immunoassays for Lyme Borreliosis Diagnostics and Pathogen Research
05:25

Author Spotlight: Expanding the Scope of Multiplex Immunoassays for Lyme Borreliosis Diagnostics and Pathogen Research

Published on: July 14, 2023

1.5K
Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
08:48

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

3.0K

Related Experiment Videos

Last Updated: Aug 9, 2025

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

503
Author Spotlight: Expanding the Scope of Multiplex Immunoassays for Lyme Borreliosis Diagnostics and Pathogen Research
05:25

Author Spotlight: Expanding the Scope of Multiplex Immunoassays for Lyme Borreliosis Diagnostics and Pathogen Research

Published on: July 14, 2023

1.5K
Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
08:48

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

3.0K

Related Concept Videos

Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

14
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
14

Articles linked to this work by shared authors, journal, and citation graph.

Clinical and Histopathologic Spectrum of Primary Nonfunction in Renal Allografts.

Kidney international reports·2026

Quantitative serological detection of NELL1 autoantibodies in membranous nephropathy.

Kidney international·2026

Multiplexed Detection of Membranous Nephropathy Antigens by Multi-Reaction Monitoring Mass Spectrometry.

Kidney international reports·2026

Clinical and histologic predictors of non-diabetic kidney disease in patients with diabetes mellitus.

Kidney international·2026

Dual-antigen membranous nephropathy.

Kidney international·2025

Spectrum of Kidney Pathology in Patients With Syphilis.

Kidney international reports·2025

AMAP-APP: Efficient Segmentation and Morphometry Quantification of Fluorescent Microscopy Images of Podocytes.

Kidney360·2026

Urgent Start of Peritoneal Dialysis Versus Hemodialysis in Kidney Failure in Severe Metabolic Acidosis: A Prospective Study.

Kidney360·2026

Targeted-Release Formulation Budesonide (Nefecon) for the Treatment of IgA Nephropathy in Three Adolescents.

Kidney360·2026

Acute Kidney Injury Duration After Cisplatin Treatment and Subsequent CKD Risk: A Single-Center Retrospective Study.

Kidney360·2026

Handgrip Strength for Mortality Prediction in Hemodialysis Patients Using the Chronological-to-Metabolic Age Ratio: A Multicenter Prospective Cohort Study.

Kidney360·2026

Heavy Numbers: When Obesity Tips the Balance between Creatinine- and Cystatin C-Based eGFR.

Kidney360·2026

Senescent tumor cell membrane-based "time engine" nanosystem amplifies endoplasmic reticulum targeting for metastasis blockade.

Science advances·2026

Research progress in synergistic multimechanism of nanomaterial-mediated neuroinflammatory therapy (Review).

Molecular medicine reports·2026

Silver sodium nitroprusside nano-aggregates for ultrasound-activated immunomodulatory therapy of MRSA pneumonia.

Biomedical materials (Bristol, England)·2026

Neuro-psycho MMSig: multimodal mechanism enrichment platform for neuropsychiatric disorders.

Frontiers in bioinformatics·2026

Portable Ultra-Low-Field MRI in Neurologic Diseases: Current Status and Potential in Clinical Practice, Research, and Trials.

Neurology·2026

Venetoclax-based therapy versus hypomethylating agents alone in unfit patients with newly diagnosed acute myeloid leukemia: a real-world study from the PETHEMA registry.

Leukemia·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us